171 related articles for article (PubMed ID: 28671633)
21. Insight into Bortezomib Focusing on Its Efficacy against P-gp-Positive MDR Leukemia Cells.
Kyca T; Pavlíková L; Boháčová V; Mišák A; Poturnayová A; Breier A; Sulová Z; Šereš M
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071136
[TBL] [Abstract][Full Text] [Related]
22. Chk1 Inhibitor MK-8776 Restores the Sensitivity of Chemotherapeutics in P-glycoprotein Overexpressing Cancer Cells.
Cui Q; Cai CY; Wang JQ; Zhang S; Gupta P; Ji N; Yang Y; Dong X; Yang DH; Chen ZS
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31443367
[TBL] [Abstract][Full Text] [Related]
23. Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transporters.
Fan YF; Zhang W; Zeng L; Lei ZN; Cai CY; Gupta P; Yang DH; Cui Q; Qin ZD; Chen ZS; Trombetta LD
Cancer Lett; 2018 May; 421():186-198. PubMed ID: 29331420
[TBL] [Abstract][Full Text] [Related]
24. Combined treatment of P-gp-positive L1210/VCR cells by verapamil and all-trans retinoic acid induces down-regulation of P-glycoprotein expression and transport activity.
Sulová Z; Macejová D; Seres M; Sedlák J; Brtko J; Breier A
Toxicol In Vitro; 2008 Feb; 22(1):96-105. PubMed ID: 17920233
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of KL-6/MUC1 glycosylation limits aggressive progression of pancreatic cancer.
Xu HL; Zhao X; Zhang KM; Tang W; Kokudo N
World J Gastroenterol; 2014 Sep; 20(34):12171-81. PubMed ID: 25232251
[TBL] [Abstract][Full Text] [Related]
26. Aberrant O-glycosylation inhibits stable expression of dysadherin, a carcinoma-associated antigen, and facilitates cell-cell adhesion.
Tsuiji H; Takasaki S; Sakamoto M; Irimura T; Hirohashi S
Glycobiology; 2003 Jul; 13(7):521-7. PubMed ID: 12672699
[TBL] [Abstract][Full Text] [Related]
27. N-Glycans influence the in vitro adhesive and invasive behaviour of three metastatic cell lines.
Bironaite D; Nesland JM; Dalen H; Risberg B; Bryne M
Tumour Biol; 2000; 21(3):165-75. PubMed ID: 10754467
[TBL] [Abstract][Full Text] [Related]
28. The FLT3 inhibitor midostaurin selectively resensitizes ABCB1-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents.
Hsiao SH; Lusvarghi S; Huang YH; Ambudkar SV; Hsu SC; Wu CP
Cancer Lett; 2019 Mar; 445():34-44. PubMed ID: 30639533
[TBL] [Abstract][Full Text] [Related]
29. Permanent exposure of mucin-secreting HT-29 cells to benzyl-N-acetyl-alpha-D-galactosaminide induces abnormal O-glycosylation of mucins and inhibits constitutive and stimulated MUC5AC secretion.
Hennebicq-Reig S; Lesuffleur T; Capon C; De Bolos C; Kim I; Moreau O; Richet C; Hémon B; Recchi MA; Maës E; Aubert JP; Real FX; Zweibaum A; Delannoy P; Degand P; Huet G
Biochem J; 1998 Aug; 334 ( Pt 1)(Pt 1):283-95. PubMed ID: 9693131
[TBL] [Abstract][Full Text] [Related]
30. Isopetasin and S-isopetasin as novel P-glycoprotein inhibitors against multidrug-resistant cancer cells.
Abdelfatah S; Böckers M; Asensio M; Kadioglu O; Klinger A; Fleischer E; Efferth T
Phytomedicine; 2021 Jun; 86():153196. PubMed ID: 32229058
[TBL] [Abstract][Full Text] [Related]
31. The anti-estrogen receptor drug, tamoxifen, is selectively Lethal to P-glycoprotein-expressing Multidrug resistant tumor cells.
Bakadlag R; Limniatis G; Georges G; Georges E
BMC Cancer; 2023 Jan; 23(1):24. PubMed ID: 36609245
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of the multidrug resistance genes mdr1, mdr3, and mrp in L1210 leukemia cells resistant to inhibitors of ribonucleotide reductase.
Rappa G; Lorico A; Liu MC; Kruh GD; Cory AH; Cory JG; Sartorelli AC
Biochem Pharmacol; 1997 Sep; 54(6):649-55. PubMed ID: 9310341
[TBL] [Abstract][Full Text] [Related]
33. Protein O glycosylation regulates activation of hepatic stellate cells.
Fan X; Chuan S; Hongshan W
Inflammation; 2013 Dec; 36(6):1248-52. PubMed ID: 23743764
[TBL] [Abstract][Full Text] [Related]
34. Combination of 7-
Chen Y; Li X; Shi L; Ma P; Wang W; Wu N; Gan Y; Han X; Huang S; Kang X; Liu S; Zhen Y
Aging (Albany NY); 2022 Sep; 14(17):7156-7169. PubMed ID: 36107024
[TBL] [Abstract][Full Text] [Related]
35. Fluorinated carbohydrates as potential plasma membrane modifiers. Synthesis of 4- and 6-fluoro derivatives of 2-acetamido-2-deoxy-D-hexopyranoses.
Sharma M; Bernacki RJ; Paul B; Korytnyk W
Carbohydr Res; 1990 May; 198(2):205-21. PubMed ID: 2379186
[TBL] [Abstract][Full Text] [Related]
36. Glycosylation of P-glycoprotein in a multidrug-resistant KB cell line, and in the human tissues.
Ichikawa M; Yoshimura A; Furukawa T; Sumizawa T; Nakazima Y; Akiyama S
Biochim Biophys Acta; 1991 Mar; 1073(2):309-15. PubMed ID: 1672608
[TBL] [Abstract][Full Text] [Related]
37. Tetrandrine Interaction with ABCB1 Reverses Multidrug Resistance in Cancer Cells Through Competition with Anti-Cancer Drugs Followed by Downregulation of ABCB1 Expression.
Liao D; Zhang W; Gupta P; Lei ZN; Wang JQ; Cai CY; Vera AA; Zhang L; Chen ZS; Yang DH
Molecules; 2019 Nov; 24(23):. PubMed ID: 31801248
[TBL] [Abstract][Full Text] [Related]
38. The human KB multidrug-resistant cell line KB-C1 is hypersensitive to inhibitors of glycosylation.
Bentley J; Quinn DM; Pitman RS; Warr JR; Kellett GL
Cancer Lett; 1997 May; 115(2):221-7. PubMed ID: 9149128
[TBL] [Abstract][Full Text] [Related]
39. Impact of glycosylation and detergent-resistant membranes on the function of intestinal sucrase-isomaltase.
Wetzel G; Heine M; Rohwedder A; Naim HY
Biol Chem; 2009 Jul; 390(7):545-9. PubMed ID: 19426137
[TBL] [Abstract][Full Text] [Related]
40. Cytotoxicity of cucurbitacin E from Citrullus colocynthis against multidrug-resistant cancer cells.
Saeed MEM; Boulos JC; Elhaboub G; Rigano D; Saab A; Loizzo MR; Hassan LEA; Sugimoto Y; Piacente S; Tundis R; Yagi S; Khalid H; Efferth T
Phytomedicine; 2019 Sep; 62():152945. PubMed ID: 31132750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
